Quarterly report [Sections 13 or 15(d)]

Balance Sheet Components (Tables)

v3.26.1
Balance Sheet Components (Tables)
 3 Months Ended
Mar. 31, 2026
Balance Sheet Components [Abstract]  
Schedule of Prepaid Expenses and Other Current Assets

Prepaid expenses and other current assets as of December 31, 2025 and March 31, 2026 consisted of the following (in thousands):

 

    As of     As of  
    December 31,     March 31,  
    2025     2026  
             
Prepaid directors’ and officers’ liability insurance premiums   $ 332     $ 181  
Prepaid drug manufacturing supply costs     6,189       7,689  
Other     1,171       1,089  
Total   $ 7,692     $ 8,959  
Schedule of Property and Equipment

Property and equipment as of December 31, 2025 and March 31, 2026 consisted of the following (in thousands):

 

    As of     As of  
    December 31,     March 31,  
    2025     2026  
             
Leasehold improvements   $ 65     $ 36  
Lab equipment     26       26  
Furniture and fixtures     47       44  
Subtotal     138       106  
Less accumulated depreciation     (72 )     (58 )
Net   $ 66     $ 48  
Schedule of Accounts Payable

Accounts payable as of December 31, 2025 and March 31, 2026 consisted of the following (in thousands):

 

    As of     As of  
    December 31,     March 31,  
    2025     2026  
             
Trade accounts payable   $ 301     $ 1,014  
Credit card liability     82       126  
Total   $ 383     $ 1,140  
Schedule of Accrued Liabilities

Accrued liabilities as of December 31, 2025 and March 31, 2026 consisted of the following (in thousands):

 

    As of     As of  
    December 31,     March 31,  
    2025     2026  
             
Accrued labor costs   $ 329     $ 768  
Accrued drug development costs     753       631  
Other     441       1,653  
Total   $ 1,523     $ 3,052